FindTrial
Sign In

Spectroscopy for diagnosis of breast tumours

Fluorescence spectroscopy for differentiation of Fibroadenoma and Phyllodes tumor of the breast

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022352
Enrollment
30
Registered
2019-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: Fluorescence spectroscopy: Fluorescence spectroscopy is used to attempt differentiating between fibroadenoma and phyllodes tumour of the breast in ex vivo specimens Control Intervention

Sponsors

Dr Kocherlakota Sathya Priyanka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All benign lumps of the breast

Exclusion criteria

Exclusion criteria: All malignant tumors of the breast

Design outcomes

Primary

MeasureTime frame
Record fluorescence spectra of fibroadenoma and phyllodes tumour of the breastTimepoint: 2 years—

Secondary

MeasureTime frame
Determine difference in spectra of fibroadenoma and phyllodes tumor Determine sensitivity, specificity, positive predictive value and negative predictive value of fluorescence spectrometry for diagnosing fibroadenoma and phyllodes tumor.Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Badareesh L

Kasturba Medical College, Manipal

stanley.mathew@manipal.edu9844409900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026